Sandbox

Overview

A non-clinical therapy area used to rehearse end-to-end product behaviour in development and staging. It mirrors the structure of live therapy areas (fees, medicines, shipping, questionnaires) at a token price so engineers, clinicians in UAT, and operations can validate integrations without meaningful financial risk.

What is seeded in this area (typical)

• Platform medicines with minimal sale and default acquisition prices (for example £0.10 per pack on the Testing formulary)
• Royal Mail (or equivalent) delivery method labelled for testing, with shipping and handling margins at £0.01
• A questionnaire that exercises database-driven medicine options, photo upload, terminate branches, and price calculation
• Inactive SKU rows where needed to test not available display paths

Private suitability (engineering sense)

• Not a patient-facing clinical offer in production unless your governance explicitly approves
• Intended for authenticated test users, synthetic data, or controlled pilots only
• Review fees and totals are symbolic; do not use them to benchmark commercial pricing

Common questionnaire topics (pipeline checks)

• Confirmation and fee token resolution (£{{questionnaire.doctorReviewFee}} style placeholders)
• Identity or DOB steps if wired the same as live questionnaires
• Medicine pick lists from the platform formulary
• File upload and branching logic (continue vs terminate)
• Months of supply × unit price + review fee before payment

Governance

Remove or hide this area from production storefronts and patient navigation before go-live unless your information governance and clinical safety sign-off says otherwise. Medicines labelled as test stock must never be dispensed as real patient treatment without a full regulatory and pharmacy process.

The fixed medical review fee for this indication is £0.01.

This fee covers the independent clinical assessment carried out by your reviewing doctor, including reviewing your medical questionnaire, checking suitability and safety, and making a prescribing decision where appropriate.

The review fee is charged once your request is submitted for clinical assessment and is non-refundable after the review has been completed.